Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Muscarinic acetylcholine receptor M2 | ||
Ligand | BDBM50522824 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1888527 (CHEMBL4390204) | ||
Ki | 2.6±n/a nM | ||
Citation | Yamashita, Y; Tanaka, KI; Yamakawa, N; Asano, T; Kanda, Y; Takafuji, A; Kawahara, M; Takenaga, M; Fukunishi, Y; Mizushima, T Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity. Bioorg Med Chem27:3339-3346 (2019) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Muscarinic acetylcholine receptor M2 | |||
Name: | Muscarinic acetylcholine receptor M2 | ||
Synonyms: | ACM2_HUMAN | CHRM2 | Cholinergic, muscarinic M2 | Muscarinic acetylcholine receptor M2 and M4 | Muscarinic acetylcholine receptor M2 and M5 | RecName: Full=Muscarinic acetylcholine receptor M2 | ||
Type: | GPCR | ||
Mol. Mass.: | 51730.61 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P08172 | ||
Residue: | 466 | ||
Sequence: |
| ||
BDBM50522824 | |||
n/a | |||
Name | BDBM50522824 | ||
Synonyms: | CHEMBL4521993 | ||
Type | Small organic molecule | ||
Emp. Form. | C31H33BrF3NO4 | ||
Mol. Mass. | 620.497 | ||
SMILES | [Br-].OC(C(=O)OC1C[N+]2(CCCc3ccc(OC(F)(F)F)cc3)CCC1CC2)(c1ccccc1)c1ccccc1 |(60.52,-35.48,;50.59,-37.33,;51.93,-38.1,;53.27,-38.87,;53.27,-40.41,;54.6,-38.09,;55.93,-38.86,;57.26,-38.08,;58.59,-38.86,;59.92,-38.09,;61.25,-38.86,;62.59,-38.1,;63.92,-38.87,;63.91,-40.41,;65.24,-41.18,;66.58,-40.41,;67.91,-41.19,;67.91,-42.73,;69.25,-43.5,;66.58,-43.49,;67.9,-44.27,;66.58,-38.87,;65.25,-38.1,;58.59,-40.4,;57.26,-41.16,;55.93,-40.4,;57.43,-40.2,;57.08,-39.15,;51.92,-36.56,;53.26,-35.79,;53.25,-34.25,;51.92,-33.48,;50.58,-34.27,;50.59,-35.8,;50.6,-38.88,;49.26,-38.1,;47.93,-38.88,;47.94,-40.42,;49.28,-41.18,;50.61,-40.41,)| | ||
Structure |